Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, September 16, 2021
[ Thu, Sep 16th 2021
] - WOPRAI
[ Thu, Sep 16th 2021
] - WOPRAI
[ Thu, Sep 16th 2021
] - WOPRAI
[ Thu, Sep 16th 2021
] - WOPRAI
[ Thu, Sep 16th 2021
] - WOPRAI
[ Thu, Sep 16th 2021
] - WOPRAI
[ Thu, Sep 16th 2021
] - WOPRAI
[ Thu, Sep 16th 2021
] - WOPRAI
[ Thu, Sep 16th 2021
] - WOPRAI
[ Thu, Sep 16th 2021
] - WOPRAI
[ Thu, Sep 16th 2021
] - WOPRAI
[ Thu, Sep 16th 2021
] - WOPRAI
[ Thu, Sep 16th 2021
] - WOPRAI
Wed, September 15, 2021
[ Wed, Sep 15th 2021
] - WOPRAI
[ Wed, Sep 15th 2021
] - WOPRAI
[ Wed, Sep 15th 2021
] - WOPRAI
[ Wed, Sep 15th 2021
] - WOPRAI
[ Wed, Sep 15th 2021
] - WOPRAI
[ Wed, Sep 15th 2021
] - WOPRAI
[ Wed, Sep 15th 2021
] - WOPRAI
[ Wed, Sep 15th 2021
] - WOPRAI
[ Wed, Sep 15th 2021
] - WOPRAI
[ Wed, Sep 15th 2021
] - WOPRAI
[ Wed, Sep 15th 2021
] - WOPRAI
[ Wed, Sep 15th 2021
] - WOPRAI
[ Wed, Sep 15th 2021
] - WOPRAI
Derik De Bruin Maintained (WST) at Strong Buy with Increased Target to $515 on, Sep 15th, 2021
Derik De Bruin of B of A Securities, Maintained "West Pharmaceutical Services, Inc." (WST) at Strong Buy with Increased Target from $450 to $515 on, Sep 15th, 2021.
Derik has made no other calls on WST in the last 4 months.
There are 2 other peers that have a rating on WST. Out of the 2 peers that are also analyzing WST, 1 agrees with Derik's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Jacob Johnson of "Stephens & Co." Maintained at Hold with Increased Target to $400 on, Friday, July 30th, 2021
This is the rating of the analyst that currently disagrees with Derik
- Paul Knight of "Keybanc" Maintained at Buy with Increased Target to $475 on, Friday, July 30th, 2021
